References: Heart failure with mildly reduced ejection fraction (HFmrEF)

  • Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 2021;385(16):1451-61. https://www.ncbi.nlm.nih.gov/pubmed/34449189
  • Cristal Study Group, Sidhu VS, Kelly TL, Pratt N, Graves SE, Buchbinder R, et al. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial. JAMA 2022;328(8):719-27. https://www.ncbi.nlm.nih.gov/pubmed/35997730
  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42(36):3599-726. https://www.ncbi.nlm.nih.gov/pubmed/34447992
  • NHFA CSANZ Heart Failure Guidelines Working Group, Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart Lung Circ 2018;27(10):1123-208. https://www.ncbi.nlm.nih.gov/pubmed/30077227